Matti Korhonen

4.0k total citations
80 papers, 3.1k citations indexed

About

Matti Korhonen is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Matti Korhonen has authored 80 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 21 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Matti Korhonen's work include Mesenchymal stem cell research (20 papers), Cell Adhesion Molecules Research (18 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Matti Korhonen is often cited by papers focused on Mesenchymal stem cell research (20 papers), Cell Adhesion Molecules Research (18 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Matti Korhonen collaborates with scholars based in Finland, United States and Sweden. Matti Korhonen's co-authors include Ismo Virtanen, L. Laitinen, Jari Ylänne, Johanna Nystedt, Victor E. Gould, George Κ. Koukoulis, Saara Laitinen, Petri Lehenkari, Vito Quaranta and Mika Hukkanen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Matti Korhonen

79 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Korhonen Finland 34 1.2k 786 711 622 459 80 3.1k
Ichiro Naito Japan 28 980 0.9× 1.1k 1.4× 220 0.3× 327 0.5× 220 0.5× 92 2.6k
Marja Ekblom Sweden 26 961 0.8× 786 1.0× 349 0.5× 761 1.2× 623 1.4× 55 2.9k
Jean Plouët France 38 2.9k 2.5× 413 0.5× 694 1.0× 277 0.4× 451 1.0× 69 4.5k
Yamato Kikkawa Japan 30 1.5k 1.3× 1.1k 1.4× 374 0.5× 129 0.2× 332 0.7× 104 3.5k
Carlijn Voermans Netherlands 32 985 0.9× 196 0.2× 566 0.8× 585 0.9× 845 1.8× 73 2.7k
R. Grant Rowe United States 26 2.2k 1.9× 372 0.5× 908 1.3× 217 0.3× 346 0.8× 49 3.9k
Shadmehr Demehri United States 29 868 0.8× 330 0.4× 1.0k 1.5× 304 0.5× 927 2.0× 92 3.2k
Kevin P. McHugh United States 27 2.1k 1.8× 833 1.1× 975 1.4× 105 0.2× 520 1.1× 45 3.3k
Erika Gustafsson Sweden 25 2.5k 2.2× 723 0.9× 558 0.8× 209 0.3× 564 1.2× 34 4.7k
MJ Fackler United States 8 1.1k 0.9× 254 0.3× 513 0.7× 645 1.0× 853 1.9× 10 2.9k

Countries citing papers authored by Matti Korhonen

Since Specialization
Citations

This map shows the geographic impact of Matti Korhonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Korhonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Korhonen more than expected).

Fields of papers citing papers by Matti Korhonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Korhonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Korhonen. The network helps show where Matti Korhonen may publish in the future.

Co-authorship network of co-authors of Matti Korhonen

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Korhonen. A scholar is included among the top collaborators of Matti Korhonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Korhonen. Matti Korhonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nuutila, Kristo, Shintaro Katayama, Anita Laitinen, et al.. (2022). ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level. Burns. 49(5). 1144–1156. 5 indexed citations
2.
Dufva, Olli, Pilvi Maliniemi, Aleksandr Ianevski, et al.. (2019). Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity. Blood. 135(9). 597–609. 157 indexed citations
3.
Kontturi, Leena-Stiina, Anita Laitinen, Anne‐Marie Haaparanta, et al.. (2019). Chondrogenic differentiation of human bone marrow‐derived mesenchymal stromal cells in a three‐dimensional environment. Journal of Cellular Physiology. 235(4). 3497–3507. 12 indexed citations
4.
Ritari, Jarmo, et al.. (2019). Extended HLA Haplotypes and Their Impact on DPB1 Matching of Unrelated Hematologic Stem Cell Transplant Donors. Biology of Blood and Marrow Transplantation. 25(10). 1956–1964. 8 indexed citations
5.
Kaartinen, Tanja, et al.. (2019). The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes. Frontiers in Immunology. 10. 1627–1627. 45 indexed citations
6.
Jokinen, Ville, Matti Korhonen, Robin H. A. Ras, et al.. (2018). A microfluidic oxygen sink to create a targeted cellular hypoxic microenvironment under ambient atmospheric conditions. Acta Biomaterialia. 73. 167–179. 16 indexed citations
8.
Shaw, Bronwen E., Joab Chapman, Mirjam Fechter, et al.. (2013). Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. Bone Marrow Transplantation. 48(12). 1506–1509. 8 indexed citations
11.
Kilpinen, Lotta, Feven Tigistu‐Sahle, Dario Greco, et al.. (2012). Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality. Journal of Lipid Research. 54(3). 622–635. 65 indexed citations
12.
Sillat, Tarvo, Raimo Pöllänen, Pauliina Porola, et al.. (2009). Intracrine androgenic apparatus in human bone marrow stromal cells. Journal of Cellular and Molecular Medicine. 13(9b). 3296–3302. 12 indexed citations
13.
Korhonen, Matti & Ismo Virtanen. (2001). Immunohistochemical Localization of Laminin and Fibronectin Isoforms in Human Placental Villi. Journal of Histochemistry & Cytochemistry. 49(3). 313–322. 25 indexed citations
14.
Champliaud, Marie-France, et al.. (2000). Posttranslational Modifications and β/γ Chain Associations of Human Laminin α1 and Laminin α5 Chains: Purification of Laminin-3 from Placenta. Experimental Cell Research. 259(2). 326–335. 32 indexed citations
15.
Lohi, Jouni, Matti Korhonen, Ilmo Leivo, et al.. (1997). Expression of type IV collagen α1(IV)–α6(IV) polypeptides in normal and developing human kidney and in renal cell carcinomas and oncocytomas. International Journal of Cancer. 72(1). 43–49. 38 indexed citations
16.
Virtanen, Ismo, et al.. (1995). Differential expression of laminin polypeptides in developing and adult human kidney.. Journal of Histochemistry & Cytochemistry. 43(6). 621–628. 56 indexed citations
17.
Korhonen, Matti, et al.. (1994). Integrins and laminins in human renal carcinoma cells and tumors grown in nude mice.. PubMed. 54(16). 4532–8. 34 indexed citations
18.
Korhonen, Matti, Jari Ylänne, L. Laitinen, & Ismo Virtanen. (1990). The alpha 1-alpha 6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron.. The Journal of Cell Biology. 111(3). 1245–1254. 222 indexed citations
19.
Korhonen, Matti. (1984). Adenocarcinoma of the uterine cervix. Prognosis and prognostic significance of histology. Cancer. 53(8). 1760–1763. 56 indexed citations
20.
Wahlström, Torsten, Matti Korhonen, Jan Lindgren, & Markku Seppälä. (1979). DISTINCTION BETWEEN ENDOCERVICAL AND ENDOMETRIAL ADENOCARCINOMA WITH IMMUNOPEROXIDASE STAINING OF CARCINOEMBRYONIC ANTIGEN IN ROUTINE HISTOLOGICAL TISSUE SPECIMENS. The Lancet. 314(8153). 1159–1160. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026